ZEISS India Appoints Baskar Kesavalu as Head of Vision Technology Solutions

Bangalore, India – February 11, 2025: ZEISS, a pioneer of science in optics and optoelectronics, has appointed Baskar Kesavalu as Head of Vision Technology Solutions (VTS), ZEISS India. He will be responsible for overseeing VTS Research & Development, Quality Assurance & Regulatory Affairs, and Product Management in India. He joins at a time when ZEISS is strengthening its ties in India by growing its business through investments, strategic alliances, and launches.

Baskar has more than 30 years of experience in the defense, healthcare, and consumer electronics industries. Before joining ZEISS India, he worked at GE HealthCare, where he was responsible for creating mission-critical patient monitoring systems and cloud-native medical solutions for hospitals throughout the United States and Europe. He has also been associated with brands like Cisco Systems and ST Microelectronics.

With his expertise in technology leadership, product development, and agile transformation, Baskar has helped successfully build and manage teams across multiple locations, including Bangalore and Milwaukee, USA. He specializes in the Scaled Agile Framework (SAFe), Continuous Integration & Continuous Deployment (CI/CD), and DevOps, ensuring high-quality and efficient product development

Baskar holds a Master of Science in Software Engineering from the National University of California and an Executive General Management Program credential from the Indian Institute of Management (IIM), Bengaluru. With a strong focus on collaboration and innovation, he is known for building high-performing teams and fostering a culture of excellence in technology and product development.

For more information on ZEISS please visit https://www.zeiss.com/corporate/en/home.html

About ZEISS Group:

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling 10.9 billion euros in its four segments Semiconductor Manufacturing Technology, Industrial Quality & Research, Medical Technology and Consumer Markets (status: 30 September 2023).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world’s leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future of technology and constantly advancing the world of optics and related fields with its solutions. The company’s significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS’ technology and market leadership. ZEISS invests 15 percent of its revenue in research and development – this high level of expenditure has a long tradition at ZEISS and is also an investment in the future.

With around 46,485 employees, ZEISS is active globally in almost 50 countries with around 30 production sites, 60 sales and service companies and 27 research and development facilities (status: 30 September 2023). Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information at www.zeiss.com